Molecular Profiling of Antipsychotic Drug Function: Convergent Mechanisms in the Pathology and Treatment of Psychiatric Disorders
- 1 January 2006
- journal article
- review article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 34 (2) , 109-128
Abstract
Despite great progress in antipsychotic drug research, the molecular mechanisms by which these drugs work have remained elusive. High-throughput gene profiling methods have advanced this field by allowing the simultaneous investigation of hundreds to thousands of genes. However, different methodologies, choice of brain region, and drugs studied have made comparisons across different studies difficult. Because of the complexity of gene expression changes caused by drugs, teasing out the most relevant expression differences is a challenging task. One approach is to focus on gene expression changes that converge on the same systems that were previously deemed important to the pathology of psychiatric disorders. From the microarray studies performed on human postmortem brain samples from schizophrenics, the systems most implicated to be dysfunctional are synaptic machinery, oligodendrocyte/myelin function, and mitochondrial/ubiquitin metabolism. Drugs may act directly or indirectly to compensate for underlying pathological deficits in schizophrenia or via other mechanisms that converge on these pathways. Side effects, consisting of motor and metabolic dysfunction (which occur with typical and atypical drugs, respectively), also may be mediated by gene expression changes that have been reported in these studies. This article surveys both the convergent antipsychotic mechanisms and the genes that may be responsible for other effects elicited by antipsychotic drugs.Keywords
This publication has 98 references indexed in Scilit:
- Quantitative Assessment of Transcriptome Differences Between Brain TerritoriesGenome Research, 2003
- Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary studySchizophrenia Research, 2002
- Gene expression profiling in the post-mortem human brain — no cause for dismayJournal of Chemical Neuroanatomy, 2001
- Bacterially produced apolipoprotein D binds progesterone and arachidonic acid, but not bilirubin orE-3M2HJournal of Molecular Recognition, 2001
- RGS9: A regulator of G-protein signalling with specific expression in rat and mouse striatumJournal of Neuroscience Research, 1998
- Functional and Anatomical Aspects of Prefrontal Pathology in SchizophreniaSchizophrenia Bulletin, 1997
- Obesity and the Insulin Resistance SyndromeHypertension Research, 1996
- Arachidonic acid binds to apolipoprotein D: implications for the protein's functionFEBS Letters, 1995
- The role of 5-HT2A receptors in antipsychotic activityLife Sciences, 1995
- Isolation and partial characterization of apolipoprotein D: A new protein moiety of the human plasma lipoprotein systemFEBS Letters, 1973